An osteoanabolic agent should be the first choice treatment for patients at high or imminent risk for fracture, but once ...

Metabolic bone diseases represent a substantial and growing global health concern, with conditions such as osteoporosis, osteoarthritis, Paget's disease, ...

Among patients with chronic hypoparathyroidism, palopegteriparatide improved skeletal dynamics and renal function at 2 years, ...

It's treatable and sometimes temporary. It's when your body doesn't have enough parathyroid hormone (PTH). That's a hormone made in four pea-sized lobes in your neck called parathyroid glands.

Excess thyroid hormone is, however, associated with unwanted effects on the heart, bone and skeletal muscle. We therefore need analogs that harness the beneficial effects of thyroid hormone ...

AACE released clinical guidelines on the diagnosis, management, and surveillance of tumors related to multiple endocrine ...

MBX Biosciences is advancing a unique prodrug pipeline with key GLP-1 assets and a pivotal Phase 2 readout in ...

The Bone Density Solution by Shelly Manning, published by Blue Heron Health News, is a comprehensive 14-step program designed to address the underlying causes of osteoporosis through natural ...

Somapacitan is a human growth hormone analog currently marketed under the brand name Sogroya for the treatment of pediatric patients aged 2.5 years and older who have growth failure due to ...